Impact of Surface Charge-Tailored Gold Nanorods for Selective Targeting of Mitochondria in Breast Cancer Cells Using Photodynamic Therapy.
Nadar Manimaran VinitaUmapathy DevanSabapathi DurgadeviSelvaraj AnithaMuthusamy GovarthananArockiam Antony Joseph VelanganniJeyakanthan JeyaramanPitchan Arul PrakashMohamed Sultan Mohamed JaabirPonnuchamy KumarPublished in: ACS omega (2023)
Herein, the impact of surface charge tailored of gold nanorods (GNRs) on breast cancer cells (MCF-7 and MDA-MB-231) upon conjugation with triphenylphosphonium (TPP) for improved photodynamic therapy (PDT) targeting mitochondria was studied. The salient features of the study are as follows: (i) positive (CTAB@GNRs) and negative (PSS-CTAB@GNRs) surface-charged gold nanorods were developed and characterized; (ii) the mitochondrial targeting efficiency of gold nanorods was improved by conjugating TPP molecules; (iii) the conjugated nanoprobes (TPP-CTAB@GNRs and TPP-PSS-CTAB@GNRs) were evaluated for PDT in the presence of photosensitizer (PS), 5-aminolevulinic acid (5-ALA) in breast cancer cells; (iv) both nanoprobes (TPP-CTAB@GNRs and TPP-PSS-CTAB@GNRs) induce apoptosis, damage DNA, generate reactive oxygen species, and decrease mitochondrial membrane potential upon 5-ALA-based PDT; and (v) 5-ALA-PDT of two nanoprobes (TPP-CTAB@GNRs and TPP-PSS-CTAB@GNRs) impact cell signaling (PI3K/AKT) pathway by upregulating proapoptotic genes and proteins. Based on the results, we confirm that the positively charged (rapid) nanoprobes are more advantageous than their negatively (slow) charged nanoprobes. However, depending on the kind and degree of cancer, both nanoprobes can serve as efficient agents for delivering anticancer therapy.
Keyphrases
- photodynamic therapy
- fluorescence imaging
- breast cancer cells
- reactive oxygen species
- oxidative stress
- cell death
- reduced graphene oxide
- cell cycle arrest
- cell therapy
- gene expression
- squamous cell carcinoma
- genome wide
- climate change
- signaling pathway
- single cell
- cell proliferation
- cell free
- young adults
- loop mediated isothermal amplification
- replacement therapy
- genome wide identification